Skip to main content
SpringerLink
Log in

In vitro studies with fexofenadine, a new nonsedating histamine H1 receptor antagonist, on isolated human basophils

  • Published:
Inflammation Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. PsoriSol Centre for Dermatology and Allergy, Mühlstrasse 31, 91217 Hersbruck, Germany, Fax +49 9151 72 94 19, e-mail: Amon@psorisol.de, , , , , , DE

    U. Amon & S. Amon

  2. Medical University of Lübeck, Department of Dermatology, Ratzeburger Allee 160, 23538 Lübeck, Germany , , , , , , DE

    B. F. Gibbs

Authors
  1. U. Amon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Amon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. F. Gibbs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amon, U., Amon, S. & Gibbs, B. In vitro studies with fexofenadine, a new nonsedating histamine H1 receptor antagonist, on isolated human basophils. Inflamm. res. 49 (Suppl 1), 13–14 (2000). https://doi.org/10.1007/PL00000160

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00000160

Keywords

Search

Navigation